Strategic merger Leverage the merger with BluePath Solutions to position QualiaBio as a broader service provider across value marketing, health economics, outcomes research, policy, market access, and reimbursement, creating cross-sell opportunities to existing clients and attracting new ones seeking integrated solutions.

Access market expansion Target pharmaceutical manufacturers and CROs aiming to streamline product access and payer strategy, offering end-to-end services from health economic modeling to reimbursement strategy to differentiate from competitors with a unified value proposition.

Emerging client segments Explore opportunities with small to mid-size biopharma companies in need of affordable, comprehensive market access planning and outcomes research, leveraging the startup scale and flexibility of QualiaBio post-merger.

Digital footprint leverage Utilize the combined firm’s digital infrastructure and analytics tools (Cloudflare, Google tags, Nuxt.js) to deliver data-driven marketing and performance measurement for clients, offering enhanced digital HEOR and payer communications capabilities.

Financial positioning With current revenue in the startup range, emphasize rapid value delivery and scalable pricing models to win early customers while building case studies and measurable ROI to attract larger enterprise clients.